Revolutionizing Stem Cell Research

Learn More About 123Genetix


welcome message

Dr. Wayne Danter
Ceo & CSO & Founder

“Rare should not mean forgotten. We are working hard to empower global Medical Research with an initial focus on Rare Diseases.”

Meet our team


Dr. W.R. Danter


tom Diavolitsis

Business Development

walter huber

Finance &

Dr. Jim Koropatnick

Scientific Advisor

Paul Barge

Business Development

our progress to date

  • 17 rare disease simulations completed – growing online repository at
  • Identified key personnel for CFO, BD, Data Science and Science Advisory board, Intellectual property and Research assistance
  • 2 research programs initiated with Key Opinion Leaders
  • Overview of 123Genetix’s platform technology – in Orphanet Journal of Rare Diseases, 2019, 14:13
  • Intellectual Property strategy initiated for first potential drug candidate class
  • Recipient of BURST grant, March, 2019, (TECHALLIANCE, London)

What People are saying

Jim Koropatnick and 123Genetix have been extraordinarily useful in guiding our nationally-funded research strategy to explore therapeutic targeting of DNA repair in human tumors

Jim Koropatnick

Jim Koropatnick, PhD, Western University

123Genetix has found the sweet spot in applying computer simulations to speed up disease modeling in stem cell research

Lisa Schellenberg

Entrepreneur-in-Residence, TechAlliance of Southwestern Ontario

The ground breaking work being done by 123Genetix provides new hope for patients and their families who are suffering from rare diseases

Rob Brunet

ntellectual Property Expert

If you are interested in Rare Disease research and haven’t spoken to Dr. Wayne Danter yet, check out the work he is doing

Rebecca Stewart

CEO, Rare Revolution Magazine and Co-Founder & Trustee of Teddington Trust, Aberdeen, UK